Boston Scientific (BSX) PT Raised to 'Street High' $53 at Needham & Company Amid Completion of BTG Deal
Tweet Send to a Friend
Needham & Company analyst Mike Matson raised the price target on Boston Scientific (NYSE: BSX) to $53.00 (from $46.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
